Balloon-expandable, self-expanding TAVR valves associated with comparable long-term outcomes

cardiologists heart doctors heart research heart data

Patients treated with the Sapien 3 platform from Edwards Lifesciences and the Evolut platform from Medtronic were linked to more similarities than differences after six years. This was a single-center study, researchers noted, but it does provide an in-depth look at the safety and effectiveness of TAVR.